Neurological Disease Severity Assessment Study

Full Study Name

Sponsor

University of Manchester

Local Principal Investigator

Aimee Donald

Study Status

recruiting

Main Aims

To evaluate the use of new technology as a way of monitoring disease severity in patients with neurological diseases.

Inclusion Criteria

Over the age of five years
Be able to participate in more than three of the study procedures
Written Ethics Committee (EC) approved informed consent obtained from the patient, or patient’s parent or legal
Guardian and patient assent if appropriate

Exclusion Criteria

Unrelated co-morbid condition limiting life expectancy to less than 6 months
Patient or if applicable, parent or legal guardian is unable to comprehend, sign and date the EC approved informed
Consent form and patient assent as appropriate
If determined unsuitable for the study by the investigator

Open Sites

Manchester, Royal Free, Great Ormond Street, Cambridge, UCLH

For more information click here